All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Bridgebio
AT&T Ruby
Acoramidis
Bayonetta
Muttrah
Bridgebio
Amvuttra
Bridgebio
Stock
Bbio Stock
Attruby
Acoramidis
Bridgebio
Locations
Bridgebio
Commercial
Bridgebio
Neil Kumar
Infigratinib
Bridgebio
Rare Rundown
Attruby
vs Vyndamax
Bridge BIO CEO
Neil Kumar
YouTube
Bridgebio
Beyonttra Acoramidis
Bridge Bio DCF
Bridgebio
Pipeline
Teja Reddi
Bridgebio
Bridgebio
Oncology Therapeutics
Bridgebio
Pharma Medicine for Height
Neil Kumar
Bridgebio Drug
www Egnyte Com
Aomr Stock Price Today
Attruby
Commercial 2025
Attruby
Commercial 2025 Location
Deidre
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Bridgebio
AT&T Ruby
Acoramidis
Bayonetta
Muttrah
Bridgebio
Amvuttra
Bridgebio
Stock
Bbio Stock
Attruby
Acoramidis
Bridgebio
Locations
Bridgebio
Commercial
Bridgebio
Neil Kumar
Infigratinib
Bridgebio
Rare Rundown
Attruby
vs Vyndamax
Bridge BIO CEO
Neil Kumar
YouTube
Bridgebio
Beyonttra Acoramidis
Bridge Bio DCF
Bridgebio
Pipeline
Teja Reddi
Bridgebio
Bridgebio
Oncology Therapeutics
Bridgebio
Pharma Medicine for Height
Neil Kumar
Bridgebio Drug
www Egnyte Com
Aomr Stock Price Today
Attruby
Commercial 2025
Attruby
Commercial 2025 Location
Deidre
Deirdre Bolton Prosek
Women in Telecom Ads with Morgan Freeman
Meg Tirrell Interview
Acoramidis Presentation
The N2 Company Area Director Job Legit
Morgan Freeman Amyloidosis Commercial
Commercial 2025 Scary Phone
Attr Amyloidosis with Cardiomyopathy
Neil Kumar CBC News
Attrcm What Is It
Time for Ind. and NDA Approval by the FDA
ATTR-CM Hospitalization Consequences | Attruby® (acoramidis)
8 months ago
linkedin.com
The News That Could Stoke BridgeBio, Up 80% This Year
7 months ago
investors.com
Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
Nov 22, 2024
marketscreener.com
2:09
Learn more about how Attruby can help adults with ATTR-cardiac amyloidosis. Please see Important Safety Information at Attruby.com/#ISI for Attruby® (acoramidis) and Full Prescribing Information and Patient Information at Attruby.com/PI. | Morgan Freeman
23.4K views
7 months ago
Facebook
Morgan Freeman
Acoramidis: A Potential Breakthrough Treatment for Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) | Cardiology
Jul 18, 2023
labroots.com
BridgeBio Pharma, Inc.: BEYONTTRA (acoramidis), the First Near Complete TTR Stabilizer (=90%), Approved by the European Commission to Treat ATTR-CM
6 months ago
finanznachrichten.de
Impact of Attruby on serum TTR levels
5 months ago
linkedin.com
0:59
Please see Important Safety Information at Attruby.com/#ISI for Attruby™ (acoramidis) and Full Prescribing Information and Patient Information at Attruby.com/PI. #SponsoredbyAttruby It’s an honor to work with the BridgeBio team to raise awareness for ATTR-cardiac amyloidosis (ATTR-CM) and the help Attruby can give to those with the disease. Visit Attruby.com to learn more about the impact of this treatment. For US audiences only. | Morgan Freeman
57.5K views
11 months ago
Facebook
Morgan Freeman
0:40
New Breakthrough in Heart Failure Treatment: Acoramidis for ATTR-CM
1.9K views
Dec 5, 2024
YouTube
MUSC Health
BridgeBio Pharma, Inc.: Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM
Mar 31, 2025
finanznachrichten.de
BridgeBio Pharma reports Attruby product revenue $146 mln in Q4
4 months ago
marketscreener.com
BridgeBio Pharma: ATTRibute-CM Study Fails To Meet Primary Endpoint At Month 12
Dec 27, 2021
nasdaq.com
Attruby TV Spot, 'A Diagnosis Doesn't Define You' Featuring Morgan Freeman
Apr 1, 2025
iSpot.tv
Morgan Freeman on Instagram: "Please see Important Safety Information, Full Prescribing Information, and Patient Information at @attruby_pi. Morgan Freeman does not live with ATTR-CM. #SponsoredbyAttruby It’s an honor to work with the BridgeBio team to raise awareness for ATTR-cardiac amyloidosis (ATTR-CM) and the help Attruby can give to those with the disease. Visit Attruby.com to learn more about the impact of this treatment. For US audiences only."
95.3K views
11 months ago
Instagram
morganfreeman
BridgeBio Pharma, Inc.: BridgeBio Announces Commercial Progress, Program Updates, and 2025 Milestones
Jan 13, 2025
finanznachrichten.de
3:29
Lawrence Livermore National Lab on Instagram: "In a milestone for supercomputing-aided drug design, @Livermore_lab and BridgeBio Oncology Therapeutics announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer. Explore how this pioneering effort could accelerate the development of new treatments, offering renewed hope for patients worldwide. Learn more at the link in our bio."
5.1K views
Jun 6, 2024
Instagram
livermore_lab
LLNL and BridgeBio announce trials for supercomputing-discovered cancer drug
2 months ago
llnl.gov
Early Diagnosis of Transthyretin Amyloid Cardiomyopathy
9 months ago
medscape.com
4:51
ATTRUBY - FDA NDA approval - 2024-11-22
222 views
Dec 11, 2024
YouTube
Inside Drug Discovery
1:01
Learn more about how Attruby can help adults with ATTR-cardiac amyloidosis. #morganfreeman #learn
112 views
6 months ago
YouTube
Morgan Freeman
BridgeBio's Most 'Hotly Debated' Drug Scores Big In Phase 3
3 months ago
investors.com
We’re honored to be recognized at this year’s Med Ad News Manny Awards with four nominations! Our work on Attruby’s “Golden Years” campaign with BridgeBio has been nominated for Best Consumer Print… | GSW, powered by Syneos Health
1 month ago
linkedin.com
19:42
罕見疾病新星爆發!BridgeBio (BBIO) 三大新藥報捷,單挑輝瑞巨頭,2026年股價上看多少?#BBIO #BridgeBio #美股分析 #生技股 #罕見疾病 #Attruby
23 views
2 months ago
YouTube
來聽美股吧
7:33
罕見疾病新星爆發!BridgeBio (BBIO) 三大新藥報捷,單挑輝瑞巨頭,2026年股價上看多少?#BBIO #BridgeBio #美股分析 #生技股 #罕見疾病 #Attruby
45 views
2 months ago
YouTube
來聽美股吧
BridgeBio LLC
Nov 30, 2017
biospace.com
1:49
BridgeBio Raised $135M to Fund 10 Drugs at Once—Here’s How
144 views
9 months ago
YouTube
Melissa Bime
18:35
Why BridgeBio Stopped Galactosemia Gene Therapy
116 views
3 months ago
YouTube
The Galactosemia Podcast
1:52
How BridgeBio Transformed Compliance With Egnyte’s GxP Compliant Platform
124 views
Apr 30, 2025
YouTube
Egnyte
2:41
How the Attruby Digital Companion on Medisafe Can Help You Stay on Track
217 views
8 months ago
YouTube
Attruby® (acoramidis)
1:15
How to Invest in Bridgebio Pharma Inc (BBIO) Step by Step
1 views
1 month ago
YouTube
Investing Step by Step
See more
More like this
Feedback